FIRST AMENDMENT TO THE CO-PROMOTION AGREEMENT by and betweenCo-Promotion Agreement • June 27th, 2019 • Dova Pharmaceuticals Inc. • Pharmaceutical preparations
This First Amendment (this “Amendment”) to the Co-Promotion Agreement is entered into on June 27, 2019 and effective as of July 1, 2019 (the “Amendment Effective Date”) by and between Dova Pharmaceuticals, Inc., a Delaware corporation (“Dova”), and Bausch Health US, LLC, formerly known as Valeant Pharmaceuticals North America LLC, a Delaware limited liability company (collectively, “Valeant”). Dova and Valeant are each referred to individually as a “Party” and together as the “Parties”.
